SHINE Medical Technologies manufactures and supplies medical tracers and cancer treatment elements.
SHINE Medical Technologies, Inc. manufactures and supplies medical tracers and cancer treatment elements. The company offers Molybdenum-99, a light-emitting element that is administered to patients for the purpose of diagnosing and staging cancer and heart diseases. It also provides Iodine-131 that is used to treat thyroid cancer and various abnormal thyroid conditions, including hyperthyroidism, as well as to diagnose liver function, renal blood flow, and urinary tract obstruction.The company was founded in 2010 and is headquartered in Janesville, Wisconsin.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 18, 2018 | Series B | — | 3 | — | — | Detail |
Jun 24, 2015 | Grant | $149.74K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
US Department of Energy | — | Series B |
National Science Foundation | — | Series B |
Knox | — | Series B |